乌鸦传媒

A non-hormonal therapy control arm is appropriate in trials, says Neeraj Agarwal, MD

BRCAAway trial confirms role of combination in first-line setting

Multiparametric blood test demonstrated superior specificity to standard PSA testing

Tanya Jindal discusses findings from the UNITE study

Daniel Petrylak, MD, discusses efficacy and safety data from KEYNOTE-921 trial

First step toward replacing BCG therapy, says Gary Steinberg, MD

Shilpa Gupta, MD, reviews current therapies and previews the next steps in optimizing survival